Literature DB >> 16447065

Phosphaturic mesenchymal tumor (mixed connective tissue variant): a case report with spectral analysis.

Ksenya V Shelekhova1, Dmitry V Kazakov, Ondrej Hes, Vladislav Treska, Michal Michal.   

Abstract

We present a further case of a rare mesenchymal neoplasm termed phosphaturic mesenchymal tumor (mixed connective tissue variant). The patient was a 42-year-old man with a long history of osteomalacia of unknown etiology with pathological bone fracture, abnormality of parathyroid glands, kyphosis, scoliosis, and spondylosis. Laboratory investigation disclosed hypophosphatemia, elevated serum alkaline phosphatase activity, and normal serum calcium level. The patient had a soft tissue mass in the right inguinal area, measuring 11 x 6 x 5 cm, which was previously interpreted as a calcified hematoma on sonography. The tumor was surgically removed. Grossly, the tumor was well circumscribed, unencapsulated, and had soft to dense consistency. The cut surface had a variegated appearance due to the presence of large hemorrhagic areas admixed with foci of grey-yellow tissue. Histologically, the tumor was composed of primitive mesenchymal cells, osteoclast-like cells, and cells showing myofibroblastic features without cytologic atypia. There were a well developed vascular network, microcystic areas, and poorly formed cartilaginous foci. Unusual and hitherto unpublished prominent features were flower-like, slate-gray crystals, widespread hemosiderin deposits and large areas of hemorrhages, with the latter comprising approximately 60% of the tumor. A spectral analysis indicated that chemically, the crystals mainly consisted of calcium phosphate and sodium nitrate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16447065     DOI: 10.1007/s00428-005-0149-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  9 in total

1.  Oncogenous osteomalacia--report of a case.

Authors:  C Cehreli; M N Alakavuklar; C Cavdar; G Basdemir; B Undar; N Akkoc; B Payzin; F Oztop
Journal:  Acta Oncol       Date:  1994       Impact factor: 4.089

2.  Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases.

Authors:  R G Firth; C S Grant; B L Riggs
Journal:  Am J Med       Date:  1985-04       Impact factor: 4.965

Review 3.  Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia. Effect of successful tumor resection on mineral homeostasis.

Authors:  I R Reid; S L Teitelbaum; A Dusso; M P Whyte
Journal:  Am J Med       Date:  1987-08       Impact factor: 4.965

4.  Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets.

Authors:  N Weidner; D Santa Cruz
Journal:  Cancer       Date:  1987-04-15       Impact factor: 6.860

Review 5.  Review and update: oncogenic osteomalacia-rickets.

Authors:  N Weidner
Journal:  Ultrastruct Pathol       Date:  1991 Jul-Oct       Impact factor: 1.094

6.  Oncogenic osteomalacia.

Authors:  J McClure; P S Smith
Journal:  J Clin Pathol       Date:  1987-04       Impact factor: 3.411

7.  Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.

Authors:  Andrew L Folpe; Julie C Fanburg-Smith; Steven D Billings; Michele Bisceglia; Franco Bertoni; Justin Y Cho; Michael J Econs; Carrie Y Inwards; Suzanne M Jan de Beur; Thomas Mentzel; Elizabeth Montgomery; Michal Michal; Markku Miettinen; Stacey E Mills; John D Reith; John X O'Connell; Andrew E Rosenberg; Brian P Rubin; Donald E Sweet; Tuyethoa N Vinh; Lester E Wold; Brett M Wehrli; Kenneth E White; Richard J Zaino; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2004-01       Impact factor: 6.394

8.  Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: a case report.

Authors:  I M Yang; Y K Park; Y J Hyun; D Y Kim; J T Woo; S W Kim; J W Kim; Y S Kim; Y K Choi
Journal:  Korean J Intern Med       Date:  1997-01       Impact factor: 2.884

9.  Hypophosphatemic oncogenic osteomalacia: report of three new cases.

Authors:  M Papotti; M P Foschini; G Isaia; G Rizzi; C M Betts; V Eusebi
Journal:  Tumori       Date:  1988-10-31
  9 in total
  7 in total

Review 1.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

Review 2.  Tumor-Induced Osteomalacia: an Up-to-Date Review.

Authors:  Anke H Hautmann; Matthias G Hautmann; Oliver Kölbl; Wolfgang Herr; Martin Fleck
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

3.  Striking pathology gold: a singular experience with daily reverberations: sinonasal hemangiopericytoma (glomangiopericytoma) and oncogenic osteomalacia.

Authors:  Margaret Brandwein-Gensler; Gene P Siegal
Journal:  Head Neck Pathol       Date:  2012-03-20

Review 4.  Soft Tissue Special Issue: Giant Cell-Rich Lesions of the Head and Neck Region.

Authors:  Jen-Chieh Lee; Hsuan-Ying Huang
Journal:  Head Neck Pathol       Date:  2020-01-16

5.  A Pictorial Essay of Somatostatin Receptor Imaging in Tumor-Induced Osteomalacia: A Single Institutional Experience.

Authors:  Karuna Luthra; Dinesh Kumar Gauthaman; Vikram Lele
Journal:  Indian J Nucl Med       Date:  2022-03-25

6.  Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin.

Authors:  Anke H Hautmann; Josef Schroeder; Peter Wild; Matthias G Hautmann; Elisabeth Huber; Patrick Hoffstetter; Martin Fleck; Christiane Girlich
Journal:  Case Rep Endocrinol       Date:  2014-08-24

7.  CT and MR imaging features in phosphaturic mesenchymal tumor-mixed connective tissue: A case report.

Authors:  Zhenshan Shi; Yiqiong Deng; Xiumei Li; Yueming Li; Dairong Cao; Vikash Sahadeo Coossa
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.